Results 11 to 20 of about 50,613 (304)

Psoriatic arthritis [version 1; peer review: 2 approved] [PDF]

open access: yesF1000Research, 2019
Psoriasis is a multisystemic, inflammatory skin condition that can affect many areas of the body, but most commonly the extensor surfaces of the elbows and knees, and sometimes the intergluteal and umbilical area.
Vanessa Ocampo D, Dafna Gladman
doaj   +3 more sources

Psoriatic arthritis

open access: yesMedicina Clínica (English Edition), 2022
S.147-159Psoriatic Arthritis is an infl ammatory musculoskeletal disease. Its pathogenesis is still unclear. There is evidence that it results from multiple genetic and environmental factors. Approximately 30 % of the patients with psoriasis will develop
Koehm, M., Behrens, F.
core   +3 more sources

Rehabilitation in Psoriatic Arthritis

open access: yesThe Journal of Rheumatology Supplement, 2009
This article summarizes the state of the art of rehabilitation in psoriatic arthritis (PsA). Very little evidence was available to assess the efficacy of rehabilitation. Some data were borrowed from Studies on ankylosing spondylitis.
M. Atteno   +4 more
core   +6 more sources

Psoriatic Arthritis [PDF]

open access: yesAmerican Academy of Orthopaedic Surgeon, 2012
Psoriatic arthritis is a chronic inflammatory arthropathy that affects approximately 6% to 48% of patients with psoriasis. Arthritis is not correlated with the extent of skin disease. Classic radiographic findings of the involved joint include erosion, ankylosis, and fluffy periostitis.
Michael Sean, Day   +4 more
  +7 more sources

The Association of Psoriatic Arthritis with Carotid Intima-Media Thickness [PDF]

open access: yesJournal of Kerman University of Medical Sciences, 2021
Background: Previous studies have showed that psoriatic arthritis increases the risk of cardiovascular disease and atherosclerosis. On the other hand, an increased carotid intima-media thickness can be associated with atherosclerosis.
Hamidreza Talari   +4 more
doaj   +1 more source

Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trial

open access: yesBMJ Open, 2022
Introduction Psoriatic arthritis (PsA) is a complex, immune-mediated disease associated with skin psoriasis that, if left untreated, can lead to joint destruction. Up to 30% of patients with psoriasis progress to PsA.
Joseph F Merola   +23 more
doaj   +1 more source

CLINICAL PRESENTATION OF PSORIATIC ARTHRITIS AND RHEUMATOID ARTHRITIS IN EARLY STAGES - SIMILARITIES AND DIFFERENCES IN DIAGNOSIS

open access: yesArta Medica, 2023
Introduction. Psoriatic arthritis, as well as rheumatoid arthritis are presented by a heterogeneity of clinical manifestations in the early stages. Objective. Improvement of early diagnosis of psoriatic arthritis based on clinical data, laboratory and
Eugeniu Russu   +5 more
doaj   +1 more source

Epidemiology, Comorbidity and Risk Factors for Psoriatic Arthritis: A Health Insurance Claims Database Analysis

open access: yesActa Dermato-Venereologica, 2021
Psoriatic arthritis is a frequent manifestation of psoriasis, and has a high level of impact on physical func­tioning, work ability and quality of life.
Reinhardt Maximilian   +7 more
doaj   +1 more source

The Role of Gut Microbiome in Psoriatic Arthritis—A Literature Review

open access: yesPhysiologia, 2023
Psoriatic arthritis is a heterogeneous chronic autoimmune disorder characterized principally by skin lesions, arthritis, dactylitis and enthesitis.
Cristina Alexandru   +9 more
doaj   +1 more source

Identification of low-frequency TRAF3IP2 coding variants in psoriatic arthritis patients and functional characterization [PDF]

open access: yes, 2012
Introduction: In recent genome-wide association studies for psoriatic arthritis (PsA) and psoriasis vulgaris, common coding variants in the TRAF3IP2 gene were identified to contribute to susceptibility to both disease entities.
Maria Apel   +14 more
core   +1 more source

Home - About - Disclaimer - Privacy